Cargando…

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

ATRIPLA is licensed for use only in HIV-positive persons whose viral loads <50 for ≥3 months. We investigated the use of ATRIPLA as first-line antiretroviral therapy (ART) in EuroSIDA using a web-based survey performed in Autumn 2012. 96/112 clinics (85.7 %) completed the survey. Recommendations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mocroft, A., Reiss, P., Rakhmanova, A., Banhegyi, D., Phillips, A. N., De Wit, S., Ristola, M., Lundgren, J. D., Grarup, J., Kirk, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103996/ https://www.ncbi.nlm.nih.gov/pubmed/24902520 http://dx.doi.org/10.1007/s15010-014-0630-4

Ejemplares similares

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study
por: Reekie, Joanne, et al.
Publicado: (2012)

Atripla™ – HIV therapy in one pill
por: Julg, Boris, et al.
Publicado: (2008)

An update on the use of Atripla(®) in the treatment of HIV in the United States
por: Horberg, Michael A, et al.
Publicado: (2010)

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
por: Mocroft, Amanda, et al.
Publicado: (2013)

TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality
por: Efsen, Anne Marie W., et al.
Publicado: (2013)

“One pill, once daily”: what clinicians need to know about Atripla™
por: Clay, Patrick G, et al.
Publicado: (2008)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
por: Kamara, David A, et al.
Publicado: (2014)

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

Regional differences in self-reported HIV care and management in the EuroSIDA study
por: Grønborg Laut, Kamilla, et al.
Publicado: (2014)

Membranous Nephropathy in a Patient with Human Immunodeficiency Virus Shortly After Initiation of HAART with Atripla
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2019)

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
por: Mocroft, A, et al.
Publicado: (2014)

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA
por: Ryom, L, et al.
Publicado: (2010)

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
por: Peters, Lars, et al.
Publicado: (2014)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe
por: Zoufaly, Alexander, et al.
Publicado: (2014)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study
por: Sönnerborg, A, et al.
Publicado: (2010)

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study
por: Podlekareva, Daria N, et al.
Publicado: (2012)

Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
por: Moyle, G, et al.
Publicado: (2010)

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study
por: Kraef, Christian, et al.
Publicado: (2021)

Inhibition of Mast Cell Function and Proliferation by mTOR Activator MHY1485
por: Rakhmanova, Valeriya, et al.
Publicado: (2018)

Update on HIV in Western Europe
por: Nakagawa, Fumiyo, et al.
Publicado: (2014)

Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)–Positive and HIV-Negative Participants
por: Verheij, Eveline, et al.
Publicado: (2020)

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America
por: Efsen, Anne Marie W., et al.
Publicado: (2015)

Haemoglobin and anaemia in the SMART study
por: Mocroft, A, et al.
Publicado: (2010)

Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
por: Cooper, V, et al.
Publicado: (2010)

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America
por: Efsen, Anne Marie, et al.
Publicado: (2014)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study()
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2019)

First evidence of vertical Hepatozoon canis transmission in dogs in Europe
por: Schäfer, Ingo, et al.
Publicado: (2022)

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
por: Kaulich-Bartz, Josee, et al.
Publicado: (2013)

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
por: Sabin, Caroline A., et al.
Publicado: (2016)

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
por: Cozzi‐Lepri, A, et al.
Publicado: (2017)

The Potential Long-Term Comparative Effectiveness of Larotrectinib and Entrectinib for Second-Line Treatment of TRK Fusion-Positive Metastatic Lung Cancer
por: Roth, Joshua A., et al.
Publicado: (2020)

First Record of Mosquito-Borne Kyzylagach Virus in Central Europe
por: Šikutová, Silvie, et al.
Publicado: (2020)

Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project
por: Kowalska, Justyna D., et al.
Publicado: (2018)

Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections
por: Lodding, I.P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6n6ud82e92tuufvou3ml6dp2ie